Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0mAbs

Direct infusion intact mass spectrometry for rapid and sensitive characterization of antibody therapeutics in complex matrices

  1. 1Analytical Development, Servier Symphogen, Ballerup, Denmark
  2. 2Institut de Recherche Pierre Fabre, CIPF, Toulouse, France

Abstract

Native intact mass spectrometry (MS) is essential for resolving the structural heterogeneity of complex biotherapeutics. Traditionally, intact MS combines online chromatography (e.g. ion-exchange chromatography or size-exclusion chromatography). Here, we report an MS-centric, column-free direct infusion MS workflow that combines high-throughput off-line 96-well affinity purification with rapid and sensitive direct infusion MS. This approach achieves a sampling rate of ~1 min/sample with minimal sample consumption (<1 µL) and high sensitivity (detection of antibody drugs in the low µg/mL range). The method demonstrates excellent linearity (R2 ≥ 0.99) in the 1.953–500 µg/mL range, enabling relative quantitation and relative quality ranking across samples based on the deconvoluted MS signal. The utility of this direct infusion MS workflow is demonstrated through two case studies: 1) analysis of antibody-drug conjugate (ADC) stability and biotransformation in mouse serum, where direct infusion MS successfully tracked changes in drug-load distribution and average drug-to-antibody ratio; and 2) sensitive, high-throughput MS screening during early-stage bispecific antibody clone development. The workflow allows early detection of high-quality bsAb clones, providing results that show potential as an early indicator of drug quality in expanded fed-batch cultures. The serum stability study illustrates how this direct infusion MS workflow – despite being column free – can reveal critical product changes in highly complex sample matrices using a robust, rapid, and sensitive workflow. The established workflow uses commercially available instrumentation, reagents, and software, enabling easy implementation in biopharmaceutical analytical development and quality control laboratories.

Related

  1. Advancing Host Cell Protein Characterization in Monoclonal Antibody Therapeutics: A Nanoparticle-Enriched and High-Sensitivity Mass Spectrometry Approach
    Abdulafeez Akinloye, Sri Ramarathinam, Parul Mittal +8
    Journal of Proteome ResearchPeer-reviewedCC BY-NC-NDFull textPhysical chemistryPMC
  2. Rapid peptide mapping of monoclonal antibodies with direct infusion mass spectrometry
    Austin Z. Salome, Marcel Morgenstern, Alexander S. Hebert +18
    Communications ChemistryPeer-reviewedCC BY 4.0General chemistryNatureCrossref
  3. Mass Spectrometry Analysis of Low-Molecular-Weight Sulfur-Containing Metabolites from an Infusion of Scorodophloeus zenkeri Stem Barks
    Ericka Lorleil Mayindza Ekaghba, Simon Ollivier, Hélène Lavanant +6
    MoleculesPeer-reviewedCC BY 4.0General chemistryCrossref
  4. Titration-Based Assessment of Matrix Effects in Direct Infusion Mass Spectrometry
    Pontus Persson, Gabor Toth, Natália Remper +2
    Journal of the American Society for Mass SpectrometryPeer-reviewedCC BY 4.0Full textPhysical chemistryPMC
  5. Quantitative Cryogenic Orbitrap Secondary Ion Mass Spectrometry for structural characterization of lipid nanoparticles
    Joseph W Roberts, Anna Kotowska, Eduardo Aguilar-Bejarano +13
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
BibTeX
@article{kristensen2026direct,
  title = {{Direct infusion intact mass spectrometry for rapid and sensitive characterization of antibody therapeutics in complex matrices}},
  author = {Dan Bach Kristensen and Alain Beck and Clara Coll-Satue and Alexandre Nicolas and Martin Bendz and Nanna Sofie Eskesen and Martin Ørgaard and Elizabeta Madzharova and Trine Meiborg Sloth and Simon Krabbe and Søren Kofoed Rasmussen},
  journal = {mAbs},
  year = {2026},
  month = nov,
  doi = {10.1080/19420862.2026.2761105},
  url = {https://doi.org/10.1080/19420862.2026.2761105},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Direct infusion intact mass spectrometry for rapid and sensitive characterization of antibody therapeutics in complex matrices
AU  - Dan Bach Kristensen
AU  - Alain Beck
AU  - Clara Coll-Satue
AU  - Alexandre Nicolas
AU  - Martin Bendz
AU  - Nanna Sofie Eskesen
AU  - Martin Ørgaard
AU  - Elizabeta Madzharova
AU  - Trine Meiborg Sloth
AU  - Simon Krabbe
AU  - Søren Kofoed Rasmussen
PY  - 2026
DA  - 2026/11/06
JO  - mAbs
DO  - 10.1080/19420862.2026.2761105
UR  - https://doi.org/10.1080/19420862.2026.2761105
AB  - Native intact mass spectrometry (MS) is essential for resolving the structural heterogeneity of complex biotherapeutics. Traditionally, intact MS combines online chromatography (e.g. ion-exchange chromatography or size-exclusion chromatography). Here, we report an MS-centric, column-free direct infusion MS workflow that combines high-throughput off-line 96-well affinity purification with rapid and sensitive direct infusion MS. This approach achieves a sampling rate of ~1 min/sample with minimal sample consumption (<1 µL) and high sensitivity (detection of antibody drugs in the low µg/mL range). The method demonstrates excellent linearity (R2 ≥ 0.99) in the 1.953–500 µg/mL range, enabling relative quantitation and relative quality ranking across samples based on the deconvoluted MS signal. The utility of this direct infusion MS workflow is demonstrated through two case studies: 1) analysis of antibody-drug conjugate (ADC) stability and biotransformation in mouse serum, where direct infusion MS successfully tracked changes in drug-load distribution and average drug-to-antibody ratio; and 2) sensitive, high-throughput MS screening during early-stage bispecific antibody clone development. The workflow allows early detection of high-quality bsAb clones, providing results that show potential as an early indicator of drug quality in expanded fed-batch cultures. The serum stability study illustrates how this direct infusion MS workflow – despite being column free – can reveal critical product changes in highly complex sample matrices using a robust, rapid, and sensitive workflow. The established workflow uses commercially available instrumentation, reagents, and software, enabling easy implementation in biopharmaceutical analytical development and quality control laboratories.
SN  - 1942-0862
SN  - 1942-0870
ER  -